Prognostic Factors In Periampullary Tumors And Cysts

$0.00

Clinical Trial Record

Return to Clinical Trials

Study Start

2021-09-01

Primary Completion (ESTIMATED)

2035-01-01

Study Completion (ESTIMATED)

2040-01-01

Enrollment (ESTIMATED)

500

Study Overview

Prognostic Factors in Periampullary Tumors and Cysts

The project aims at analysing prognostic and predictive factors involved in diagnostics and surgical treatment of cysts and tumors in the pancreas and periampullary region using both clinical data and blood and tissue samples for biomarker development and validation.

From november 2021 an onward, study participants will be prospectively enrolled within the observational study. Before that, study participants are retrospectively enrolled. The study has a broad perspective including studies on clinical outcomes and prognostics based on patient and tumor characteristics.

Pancreas Cancer
Pancreas Neoplasm
Pancreas Cyst
Pancreatic Fistula
Pancreas Disease
Bile Duct Cancer
Periampullary Cancer
Surgery
Surgery--Complications

UmU-parpanc

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates	Results Reporting Dates	Study Record Updates
First Submitted 2021-11-30	Results First Submitted N/A	Last Update Submitted that met QC Criteria 2021-12-13
First Submitted that Met QC Criteria 2021-11-30	Results First Submitted that Met QC Criteria N/A	Last Update Posted (ACTUAL) 2022-01-05
First Posted (ACTUAL) 2021-12-14	Results First Posted N/A	Last Verified 2021-12

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
N/A

Allocation:
N/A

Interventional Model:
N/A

Masking:
N/A

Arms and Interventions

Participant Group/Arm	Intervention/Treatment

Primary Outcome Measures	Measure Description	Time Frame
Overall survival	Overall survival	10 years

Secondary Outcome Measures	Measure Description	Time Frame
Complications	Clavien-Dindo, Specific procedure related outcomes	10 years
Radical resection	Rates of R0 vs R1/2 resections	10 years

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Name: Oskar Franklin, MD/PhD

Phone Number: +4690785000

Email: oskar.franklin@umu.se

Study Contact Backup

Name: Asif Halimi, MD

Phone Number: +4690785000

Email: asif.halimi@regionvasterbotten.se

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

Recommended surgery for tumor or cyst in the pancreas or periampullary region
Information avalible in electronic journal files
Informed consent (or deceased for retrospective part of the study)

No informed consent (and still alive at study initiation)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

PRINCIPAL_INVESTIGATOR: Oskar Franklin, MD/PhD, Umeå University Hospital

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

No publications available

Learn

Resources

PatientS

Caregivers

Clinical Trial Record